Question 1

Does Marshall Wace own GANX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Marshall Wace holds 1,923,546 shares of GANX (Gain Therapeutics), worth $3.9M.

Question 2

How many shares of GANX does Marshall Wace own?

Accepted Answer

As of its Q2 2026 13F, Marshall Wace holds 1,923,546 shares of GANX (Gain Therapeutics).

Question 3

What is Marshall Wace's GANX position worth?

Accepted Answer

As of its Q2 2026 13F, Marshall Wace's GANX position is worth $3.9M.

Question 4

Is Marshall Wace buying or selling GANX?

Accepted Answer

In Q2 2026, Marshall Wace increased its GANX position by 153,758 shares (+8.7%).

Question 5

When did Marshall Wace first buy GANX?

Accepted Answer

Marshall Wace first reported GANX in its Q4 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.9M	+8.7%	$3.9M	0.0%	$2.03	29
2026-Q1	Increased	1.8M	+6.5%	$3.4M	0.0%	$2.63	28
2025-Q4	Increased	1.7M	+849.3%	$5.4M	0.0%	$3.05	44
2025-Q3	Decreased	175,107	-36.6%	$309,939	0.0%	$1.81	0
2025-Q2	Increased	276,433	+41.0%	$497,580	0.0%	$1.97	32
2025-Q1	Increased	196,026	+113.7%	$374,410	0.0%	$1.89	38
2024-Q4	New	91,738	-	$198,155	0.0%	$2.18	32

GANX7 quarters

GANX
7 quarters